Evidence map›Paper›PMID 37711885›Full record

ArticleKidney medicine2023

Persistent Disparities in Waitlisting After the Kidney Allocation System: Are We Exacerbating the Problem?

Joel T Adler, Hwarang S Han, Brian K Lee

Abstract readEditorial
In one paragraph

Article in Kidney medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joel T AdlerDivision of Transplantation, Department of Surgery and Perioperative Care, Dell Medical School at the University of Texas at Austin, Austin, TX.
Hwarang S HanDepartment of Medicine, Dell Medical School at the University of Texas at Austin, Austin, TX.
Brian K LeeDepartment of Medicine, Dell Medical School at the University of Texas at Austin, Austin, TX.

Funding

Evaluating the role of telehealth in patients with end stage kidney disease (ESKD)K08HS028476 · AHRQ · UNIVERSITY OF TEXAS AT AUSTIN · PI Joel Thomas Adler · 2022 to 2026
$721k
AHRQ HHS K08 HS028476NIDDK NIH HHS L60 DK130619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37711885
PMCPMC10498295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.